Inconsistent reporting of adolescent and young adult (AYA) status in non-interventional cancer research: a critical barrier to evidence usability
Open Access
Abstract
Inconsistent reporting of age at cancer diagnosis limits the utility of non-interventional studies focused on adolescents and young adults (AYAs), defined by the National Cancer Institute as individuals diagnosed between ages 15 and 39. Standardised reporting is essential to synthesise evidence and develop targeted interventions to address this population’s unique needs. While initiatives have emphasised reporting age at study enrolment in reporting results, there is a lack of guidance on specifying age at diagnosis—an essential detail for accurately identifying AYA status. To estimate the scope of this problem, we reviewed 734 non-interventional cancer studies published between 2018 and 2022 and found that 33% did not report age at diagnosis sufficiently to determine AYA inclusion, with no improvement over time. We recommend that future reporting guidelines explicitly require age-at-diagnosis metrics, including mean, median, range and count of participants diagnosed between ages 15 and 39, to improve data comparability of non-interventional AYA cancer research and accelerate targeted interventions. We further recommend that studies with mixed-age samples report outcomes stratified by AYA status wherever sample size permits.Keywords
This publication has 11 references indexed in Scilit:
- Prevalence of cancer survivors diagnosed during adolescence and young adulthood in the United StatesJNCI: Journal of the National Cancer Institute, 2024
- Survivorship after adolescent and young adult cancer: models of care, disparities, and opportunitiesJNCI: Journal of the National Cancer Institute, 2024
- Survival Trends Among Adolescents and Young Adults Diagnosed With Cancer in the United States: Comparisons With Children and Older AdultsJournal of Clinical Oncology, 2024
- Prevalence of Adverse Event Reporting in Adolescents and Young Adults Enrolled in Cancer Clinical TrialsJCO Oncology Practice, 2023
- ESMO Guidance for Reporting Oncology real-World evidence (GROW)Annals of Oncology, 2023
- Federated Analysis for Privacy-Preserving Data Sharing: A Technical and Legal PrimerAnnual Review of Genomics and Human Genetics, 2023
- Adolescent and young adult cancers: unmet needs and closing the gapsCurrent Opinion in Pediatrics, 2022
- Challenges and Opportunities of Epidemiological Studies to Reduce the Burden of Cancers in Young AdultsCurrent Epidemiology Reports, 2022
- Young Adult Cancer Survivorship: Recommendations for Patient Follow-up, Exercise Therapy, and ResearchJNCI Cancer Spectrum, 2020
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007